Your session is about to expire
← Back to Search
Temporary changes in an already-implanted medical device (biventricular pacemaker) for Left Ventricular Assist Device Infection
N/A
Waitlist Available
Led By Uma Srivatsa, MD
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2-5 minutes
Awards & highlights
No Placebo-Only Group
Summary
This trial is examining whether or not different settings on a pacemaker can affect the function of an LVAD.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2-5 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2-5 minutes
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
LVAD flow
LVAD power
LVAD pulsatility index (PI)
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: CohortExperimental Treatment1 Intervention
Pacemakers will be programmed to BiV pacing, left ventricular (LV) pacing, right ventricular (RV) pacing and no pacing for five minutes each. LVAD flow will be recorded every thirty seconds for five minutes with each setting. Once the interventions have been completed, all pacemakers will be returned to their original setting.
Find a Location
Who is running the clinical trial?
University of California, DavisLead Sponsor
936 Previous Clinical Trials
4,719,695 Total Patients Enrolled
University of California, San DiegoOTHER
1,170 Previous Clinical Trials
1,571,921 Total Patients Enrolled
Uma Srivatsa, MDPrincipal InvestigatorUC Davis
3 Previous Clinical Trials
27 Total Patients Enrolled
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger